Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT00811135
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* breast cancer with measurable locally recurrent or metastatic lesions;
* candidate for chemotherapy;
* HER2-positive disease;
* ECOG PS of \<=2.
Exclusion Criteria:
* previous anticancer therapy for metastatic breast cancer;
* previous radiotherapy for metastatic breast cancer (except for adjuvant radiotherapy \>=6 months before enrollment);
* chronic daily treatment with corticosteroids (\>=10mg/day), aspirin (\>325 mg/day) or clopidogrel (\>75mg/day);
* other primary tumor within last 5 years, except for adequately treated cervical cancer in situ, squamous or basal cell skin cancer;
* uncontrolled hypertension or significant cardiovascular disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00811135
Study Brief:
Protocol Section:
NCT00811135